Cargando…
Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892568/ https://www.ncbi.nlm.nih.gov/pubmed/31824977 http://dx.doi.org/10.1093/ofid/ofz497 |
| _version_ | 1783476052523220992 |
|---|---|
| author | Dong, Betty J Lopez, Maria I Grant, Robert M |
| author_facet | Dong, Betty J Lopez, Maria I Grant, Robert M |
| author_sort | Dong, Betty J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6892568 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68925682019-12-10 Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States Dong, Betty J Lopez, Maria I Grant, Robert M Open Forum Infect Dis Correspondence Oxford University Press 2019-11-29 /pmc/articles/PMC6892568/ /pubmed/31824977 http://dx.doi.org/10.1093/ofid/ofz497 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
| spellingShingle | Correspondence Dong, Betty J Lopez, Maria I Grant, Robert M Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States |
| title | Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States |
| title_full | Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States |
| title_fullStr | Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States |
| title_full_unstemmed | Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States |
| title_short | Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States |
| title_sort | response to: acceptability and feasibility of a pharmacist-led hiv pre-exposure prophylaxis program in the midwestern united states |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892568/ https://www.ncbi.nlm.nih.gov/pubmed/31824977 http://dx.doi.org/10.1093/ofid/ofz497 |
| work_keys_str_mv | AT dongbettyj responsetoacceptabilityandfeasibilityofapharmacistledhivpreexposureprophylaxisprograminthemidwesternunitedstates AT lopezmariai responsetoacceptabilityandfeasibilityofapharmacistledhivpreexposureprophylaxisprograminthemidwesternunitedstates AT grantrobertm responsetoacceptabilityandfeasibilityofapharmacistledhivpreexposureprophylaxisprograminthemidwesternunitedstates |